Reuters logo
BRIEF-Nicox launches capital increase of 597,897 euros following FDA's approval of Zerviate
June 9, 2017 / 5:47 AM / in 4 months

BRIEF-Nicox launches capital increase of 597,897 euros following FDA's approval of Zerviate

June 9 (Reuters) - NICOX SA:

* ANNOUNCED ON THURSDAY ISSUING AND ADMISSION TO TRADING ON THE EURONEXT REGULATED MARKET IN PARIS OF 597,897 NEW SHARES AWARDED TO EXISTING ACIEX SHAREHOLDERS FOLLOWING THE US FDA‘S APPROVAL OF ZERVIATE

* CAPITAL INCREASE OF NOMINAL AMOUNT OF EUR 597,897 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below